Conmed (CNMD) Tops Q4 EPS by 8c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- S&P 500, Nasdaq advance as oil eases ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- S&P Global explores potential separation of Capital IQ business
- Equities end higher as Anthropic's IPO filing buoys AI stocks
CONMED Corporation Announces Fourth Quarter and Full-Year 2020 Financial Results
January 27, 2021 4:05 PM ESTLARGO, Fla.--(BUSINESS WIRE)-- CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter ended December 31, 2020.
Fourth Quarter 2020 Highlights
Sales of $252.8 million decreased 4.5% year over year as reported and 5.2% in constant currency. Domestic revenue decreased 0.7% year over year. International revenue decreased 9.1% as reported year over year and 10.5% in constant currency. Diluted net earnings per share (GAAP) were $0.81, compared to diluted net earnings per share of $0.49 in the fourth quarter of 2019. Adjusted diluted net earnings per share(1) were $0.84 versus adjusted diluted... More


